1. Home
  2. LXRX vs ASLE Comparison

LXRX vs ASLE Comparison

Compare LXRX & ASLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • ASLE
  • Stock Information
  • Founded
  • LXRX 1995
  • ASLE 2008
  • Country
  • LXRX United States
  • ASLE United States
  • Employees
  • LXRX N/A
  • ASLE N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • ASLE Industrial Specialties
  • Sector
  • LXRX Health Care
  • ASLE Consumer Discretionary
  • Exchange
  • LXRX Nasdaq
  • ASLE Nasdaq
  • Market Cap
  • LXRX 228.8M
  • ASLE 271.8M
  • IPO Year
  • LXRX 2000
  • ASLE N/A
  • Fundamental
  • Price
  • LXRX $0.75
  • ASLE $5.82
  • Analyst Decision
  • LXRX Buy
  • ASLE Strong Buy
  • Analyst Count
  • LXRX 4
  • ASLE 3
  • Target Price
  • LXRX $3.67
  • ASLE $8.67
  • AVG Volume (30 Days)
  • LXRX 3.7M
  • ASLE 299.6K
  • Earning Date
  • LXRX 07-31-2025
  • ASLE 08-06-2025
  • Dividend Yield
  • LXRX N/A
  • ASLE N/A
  • EPS Growth
  • LXRX N/A
  • ASLE N/A
  • EPS
  • LXRX N/A
  • ASLE N/A
  • Revenue
  • LXRX $31,213,000.00
  • ASLE $320,302,000.00
  • Revenue This Year
  • LXRX N/A
  • ASLE $2.54
  • Revenue Next Year
  • LXRX N/A
  • ASLE $16.24
  • P/E Ratio
  • LXRX N/A
  • ASLE N/A
  • Revenue Growth
  • LXRX 1251.21
  • ASLE N/A
  • 52 Week Low
  • LXRX $0.28
  • ASLE $4.53
  • 52 Week High
  • LXRX $2.45
  • ASLE $8.76
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 61.01
  • ASLE 41.27
  • Support Level
  • LXRX $0.64
  • ASLE $5.66
  • Resistance Level
  • LXRX $0.77
  • ASLE $6.12
  • Average True Range (ATR)
  • LXRX 0.06
  • ASLE 0.20
  • MACD
  • LXRX 0.00
  • ASLE 0.02
  • Stochastic Oscillator
  • LXRX 76.47
  • ASLE 35.16

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About ASLE AerSale Corporation

AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.

Share on Social Networks: